Doherty researchers develop world-first AMR detection tool
A new tool that could soon revolutionise the way we identify antimicrobial resistance (AMR) has been developed by researchers at the University of Melbourne’s Microbiological Diagnostic Unit Public Health Laboratory (MDU PHL), located at the Peter Doherty Institute for Infection and Immunity (Doherty Institute).
abritAMR is an ISO-certified bioinformatics platform that is able to find AMR determinants from whole genome sequencing data and separates the identified genes into functionally relevant groups.
To date, the lack of international standards in the AMR genomics space has been a limiting factor in the ability to compare outputs from different laboratories, especially with regards to how that information is applied in the clinical context.
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
